经23G微创巩膜切口睫状体光凝术治疗难治性青光眼  

Cyclophot ocoagulation through 23G minimally invasive scleral incision treating refractory glaucoma

作　　者：侯盼[1] 邝国平[1] 

机构地区：[1]南华大学附属郴州市第一人民医院眼科,中国湖南省郴州市423000

出　　处：《国际眼科杂志》2017年第2期338-340,共3页International Eye Science

摘　　要：目的:观察经23G微创巩膜切口睫状体光凝术治疗难治性青光眼的疗效及其安全性。方法:对23例23眼难治性青光眼患者采用经23G微创巩膜切口睫状体光凝,观察术后眼压、最佳矫正视力、降眼压药物数量、并发症情况。结果:手术后眼压、最佳矫正视力及降眼压药物数量与术前相比,差异有统计学意义(P<0.05);术后并发症少。结论:经23G微创巩膜切口睫状体光凝术是一种新型且安全有效的治疗难治性青光眼的手术方法。AIM：To observe the efficacy and safety of cyclophotocoagulation through 23 G minimally invasive scleral incision in the treatment of refractory glaucoma.METHODS：Totally 23 patients（23 eyes） were taken the surgery-the cyclophotocoagulation-through 23 G minimally invasive scleral incision.We observed the changes of intraocular pressure（IOP）,the best corrected visual acuity（BCVA）,the quantity of drugs reducing intraocular pressure and complications in the pre-and post-operation.RESLUTS：Comparing with preoperative,the postoperative IOP,BCVA and the number of lOP-decreased drugs were statistically significant（P〈0.05）;the complication was fewer.CONCLUSION：The 23 G minimally invasive scleral incision cyclophotocoagulation is a new type of safe and effective surgical method for the treatment of refractory glaucoma.

关 键 词：23G 睫状体光凝 难治性青光眼 

分 类 号：R779.6[医药卫生—眼科]